Quartz

Hims & Hers stock tumbles as the FDA issues a warning about 'unapproved' weight loss drugs

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company braces for big regulatory shifts in the weight-loss drug industry.Read more...

Mar 18, 2025 - 20:41
 0
Hims & Hers stock tumbles as the FDA issues a warning about 'unapproved' weight loss drugs

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company braces for big regulatory shifts in the weight-loss drug industry.

Read more...

Read More

Tags:

Previous Article

Live updates: Nvidia CEO Jensen Huang delivers the keynote address at GTC

Next Article

Royal Caribbean and other cruise stocks are sinking right now

Related Posts

Coca-Cola is bringing back a classic to cope with tariffs

Coca-Cola is bringing back a classic to cope with tariffs

Feb 12, 2025  0

Bezos' Blue Origin has officially flown more than 50 people into space

Bezos' Blue Origin has officially flown more than 50 pe...

Feb 25, 2025  0

A new HIV prevention drug could get FDA approval this year

A new HIV prevention drug could get FDA approval this year

Feb 18, 2025  0